The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Review of sertraline and its clinical applications in psychiatric disorders
Abstract
Sertraline (Zoloft, Pfizer) has been shown in numerous controlled studies to have similar efficacy to other selective serotonin (5-HT) re-uptake inhibitors (SSRIs) in the treatment of depression and anxiety disorders. Further research is indicating that the efficacy of sertraline extends even beyond the treatment of depression and anxiety to include utility in eating disorders, premenstrual dysphoric disorder (PMDD) and possibly substance abuse treatment. Along with other SSRIs, sertraline offers several advantages over older antidepressants, including improved patient tolerability, low risk of lethality in overdose and no dependence potential. In head-to-head comparisons, sertraline appears to be at least as well-tolerated as other SSRIs and may even have a more favourable side effect profile. Low potential for pharmacokinetic drug interactions is another advantage of sertraline. Unlike fluoxetine, fluvoxamine and paroxetine, sertraline is not a potent inhibitor of any of the cytochrome P450 isoenzyme systems. As a result of its proven efficacy, good tolerability and lack of pharmacokinetic interactions, sertraline should be considered first-line in the treatment of anxiety and depressive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., & Farfel, G. M. (2000) · JAMA · doi:10.1001/jama.283.14.1837 · Cited by 690
Self-citationNeurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
Edwards, J. G., & Anderson, I. (1999) · Drugs · doi:10.2165/00003495-199957040-00005 · Cited by 458
Efficacy and Safety of Paroxetine Treatment for Chronic PTSD: A Fixed-Dose, Placebo-Controlled Study
Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1982 · Cited by 432
Fluoxetine in post‐traumatic stress disorder
Davidson, J., Roth, S., & Newman, E. (1991) · Journal of Traumatic Stress · doi:10.1002/jts.2490040309 · Cited by 412
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368 · cited 1×
“A recent meta-analysis evaluating randomised, controlled trials of SSRIs for treatment of PMDD found all of the SSRIs to be effective with the exception of fluvoxamine [45].”
MethodFluoxetine in Depressed Alcoholics: A Double-blind, Placebo-Controlled Trial
Cornelius, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200024004 · Cited by 357
Fluoxetine in post-traumatic stress disorder: Randomised, double-blind study
Connor, K. M., Sutherland, S. M., Tupler, L. A., Malik, M. L., Jonathan, R., & Davidson, T. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.17 · Cited by 353
Serotonin Syndrome Presentation of 2 Cases and Review of the Literature
Mason, P. J., Morris, V. A., & Balcezak, T. J. (2000) · Medicine · doi:10.1097/00005792-200007000-00001 · Cited by 309
The serotonin syndrome and its treatment
Gillman, P. K. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300111 · Cited by 306
Efficacy of Treatments for Posttraumatic Stress Disorder: An Empirical Review
Solomon, S. D. (1992) · JAMA · doi:10.1001/jama.1992.03490050081031 · Cited by 301
Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.391 · Cited by 289
Fluoxetine-induced akathisia: clinical and theoretical implications.
Lipinski, J. F., Mallya, G. K., Zimmerman, P., & Pope, H. G. (1989) · PubMed · Cited by 279
Greist, J. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160039008 · Cited by 243
Sertraline for social phobia: a double-blind, placebo-controlled crossover study
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1368 · Cited by 238
Sertraline Treatment for Alcohol Dependence: Interactive Effects of Medication and Alcoholic Subtype
Pettinati, H. M., Volpicelli, J. R., Kranzler, H. R., Luck, G., Rukstalis, M. R., & Cnaan, A. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200007000-00015 · Cited by 227
Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
Naranjo, C. A., Kadlec, K. E., Sanhueza, P., Woodley-Remus, D., & Sellers, E. M. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.62 · Cited by 224
Discontinuation Symptoms After Treatment With Serotonin Reuptake Inhibitors: A Literature Review
Zajecka, J., Tracy, K. A., & Mitchell, S. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0702 · Cited by 209 · cited 2×
“Symptoms that can occur after discontinuation of SSRIs include dizziness, insomnia, fatigue, anxiety, agitation, nausea, headache and sensory disturbances [78].”
BackgroundThe Serotonin Syndrome: Implicated Drugs, Pathophysiology and Management
Sporer, K. A. (1995) · Drug Safety · doi:10.2165/00002018-199513020-00004 · Cited by 197
Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: A meta-analysis
Steffens, D. C., Krishnan, K. R. R., & Helms, M. J. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)6:1<10::aid-da2>3.0.co;2-9 · Cited by 192
An open trial of fluoxetine in patients with anorexia nervosa.
Kaye, W. H., Weltzin, T. E., Hsu, L. K. G., & Bulik, C. M. (1991) · PubMed · Cited by 178
Effect of Fluoxetine on Alcohol Consumption in Male Alcoholics
Gorelick, D. A., & Paredes, A. (1992) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb01373.x · Cited by 170
Placebo-Controlled Trial of Sertraline in the Treatment of Binge Eating Disorder
McElroy, S. L., Casuto, L. S., Nelson, E. B., Lake, K. A., Soutullo, C. A., Keck, P. E., & Hudson, J. I. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.1004 · Cited by 170
Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
Grimsley, S. R., & Jann, M. W. (1992) · PubMed · Cited by 164
Pearlstein, T. B., Halbreich, U. M., Batzar, E. D., Brown, C., Endicott, J., Frank, E., Freeman, E. W., Harrison, W. M., Haskett, R. F., Stout, A. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0205 · Cited by 156
Grabowski, J. G., Rhoades, H. M., Elk, R., Schmitz, J. M., Davis, C., Creson, D., & Kirby, K. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199506000-00004 · Cited by 155
Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors
DeVane, C. L. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006934807375 · Cited by 149
Chouinard, G., Goodman, W. K., Greist, J. H., Jenike, M. A., Rasmussen, S., White, K., Hackett, E., Gaffney, M., & Bick, P. A. (1990) · PubMed · Cited by 136
Modulation of ethanol intake by serotonin uptake inhibitors.
Ca, N., Sellers, E. M., & Mo, L. (1986) · PubMed · Cited by 133
van der Linden, G. J., Stein, D. J., & van Balkom, A. J. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200008002-00004 · Cited by 130
Hoehn‐Saric, R., Ninan, P. T., Black, D. W., Stahl, S. M., Greist, J. H., Lydiard, B., McElroy, S. L., Zajecka, J., Chapman, D. S., Clary, C. M., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.76 · Cited by 128
Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence.
Brady, K. T., Sonne, S. C., & Roberts, J. M. (1995) · PubMed · Cited by 122
Self-citationZanardi, R., Franchini, L., Gasperini, M., Perez, J., & Smeraldi, E. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1631 · Cited by 117
Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression
Aguglia, E., Casacchia, M., Cassano, G. B., Faravelli, C., Ferrari, G., Giordano, P., Pancheri, P., Ravizza, L., Trabucchi, M., Bolino, F., et al. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00010 · Cited by 115
A controlled trial of fluoxetine in crack cocaine dependence
Batki, S. L., Washburn, A. M., Delucchi, K., & Jones, R. T. (1996) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(96)01233-1 · Cited by 106
(1995) · PubMed · Cited by 105
Åberg‐Wistedt, A., Ågren, H., Ekselius, L., Bengtson, F., & Åkerblad, A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00010 · Cited by 104
Akathisia, suicidality, and fluoxetine.
Hamilton, M. S., & Opler, L. A. (1992) · PubMed · Cited by 103
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system
Stahl, M. M. S., Lindquist, M., Pettersson, M., Edwards, I. R., Sanderson, J. H., Taylor, N. F. A., Fletcher, A. P., & Schou, J. S. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050357 · Cited by 97
Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog.
Tremaine, L. M., WELCH, W. M., & Ronfeld, R. A. (1989) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07667-6 · Cited by 91
Kabel, D., & Petty, F. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01686.x · Cited by 88
Placebo-controlled study of sertraline in depressed recently abstinent alcoholics
Roy, A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00509-x · Cited by 86
Human cytochromes mediating N -demethylation of fluoxetine in vitro
Moltke, L. L., Greenblatt, D. J., Duan, S. X., Schmider, J., Wright, C. E., Harmatz, J. S., Shader, R. I., & Moltke, L. L. (1997) · Psychopharmacology · doi:10.1007/s002130050362 · Cited by 86
Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., Kosten, T. R., & Rounsaville, B. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00032-5 · Cited by 81
Effects of Combined Fluoxetine and Counseling in the Outpatient Treatment of Cocaine Abusers
Covi, L., Hess, J. M., Kreiter, N. A., & Haertzen, C. A. (1995) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999509002701 · Cited by 81
Sertraline in the treatment of rape victims with posttraumatic stress disorder
ROTHBAUM, B. O., Ninan, P. T., & Thomas, L. (1996) · Journal of Traumatic Stress · doi:10.1007/bf02104108 · Cited by 79
Psychopharmacology of Antidepressants
Stahl, S. M. (1997) · Cited by 77
Jenike, M. A., Baer, L., D, P. S. M., Minichiello, W. E., Holland, A. J., & Seymour, R. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.7.923 · Cited by 73
Efficacy of treatments for posttraumatic stress disorder. An empirical review
Solomon, S. D. (1992) · JAMA · doi:10.1001/jama.268.5.633 · Cited by 66
Higley, J. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00180-2 · Cited by 64
CYP2D6 Inhibition in Patients Treated With Sertraline
Sproule, B. A., Otton, S. V., Cheung, S. W., Zhong, X. H., Romach, M. K., & Sellers, E. M. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704000-00007 · Cited by 64
Chouinard, G. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199210002-00007 · Cited by 63
Schatzberg, A. F., Haddad, P. M., Kaplan, E. M., Lejoyeux, M., Rosenbaum, J. F., Young, A. H., & Zajecka, J. (1997) · PubMed · Cited by 61
Sechter, D., Troy, S., Paternetti, S., & Boyer, P. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)80714-7 · Cited by 59
Prolonged bleeding time in a patient treated with sertraline
Calhoun, J. W., & Calhoun, D. D. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.443a · Cited by 55
Nemeroff, C. B., Ninan, P. T., Ballenger, J., Lydiard, R. B., Feighner, J. P., Patterson, W. M., & Greist, J. H. (1995) · Depression · doi:10.1002/depr.3050030402 · Cited by 52
Selective Serotonin Reuptake Inhibitors: Infrequent Medical Adverse Effects
Goldberg, R. J. (1998) · Archives of Family Medicine · doi:10.1001/archfami.7.1.78 · Cited by 51
Moffaert, M. V., Bartholomé, F., Cosyns, P. R., Nayer, A. R. D., & Mertens, C. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100505 · Cited by 51
Preskorn, S., & Magnus, R. D. (1994) · PubMed · Cited by 49
Effect of Sertraline on Protein Binding of Warfarin
Apseloff, G., Wilner, K. D., Gerber, N., & Tremaine, L. M. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199700321-00006 · Cited by 49
Effect of Sertraline on Plasma Nortriptyline Levels in Depressed Elderly
Solai, L. K., Mulsant, B. H., Pollock, B. G., Sweet, R. A., Rosen, J., Yu, K., & Reynolds, C. F. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1006 · Cited by 48
Clinical Implications of the Pharmacology of Serotonin Reuptake Inhibitors
Warrington, S. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199210002-00004 · Cited by 45
Altshuler, L. L., Pierre, J. M., Wirshing, W. C., & Ames, D. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199408000-00010 · Cited by 43
LaPorta, L. D. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199306000-00013 · Cited by 41
The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies
Sheikh, J. I., Londborg, P. D., Clary, C. M., & Fayyad, R. S. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015060-00004 · Cited by 33
An Open Trial of Sertraline for Cocaine Abuse
Kosten, T. A., Kosten, T. R., Gawin, F. H., Gordon, L. T., Hogan, I., & Kleber, H. D. (1992) · American Journal on Addictions · doi:10.1111/j.1521-0391.1992.tb00361.x · Cited by 30
Selective serotonin reuptake inhibitors in anorexia
Bergh, C. E. K., Eriksson, M., Lindberg, G., & Södersten, P. (1996) · The Lancet · doi:10.1016/s0140-6736(04)70113-0 · Cited by 29
Settle, E. C. (1993) · PubMed · Cited by 25
Naranjo, C. A., Sproule, B. A., & Knoke, D. M. (1999) · PubMed · Cited by 21
Munjack, D. J., Flowers, C., & Eagan, T. V. (1994) · Anxiety · doi:10.1002/anxi.3070010409 · Cited by 19
Methodologies and outcomes from the sertraline multicenter flexible-dose trials.
Mh, R., Wolkow, R., & Cm, C. (1998) · PubMed · Cited by 19
Reversible Choreiform Dyskinesia and Extrapyramidal Symptoms Associated With Sertraline Therapy
Madhusoodanan, S., & Brenner, R. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704000-00026 · Cited by 18
Czepowicz, V. D., Johnson, M., Lydiard, R. B., Emmanuel, N. P., Ware, M. R., Brawman‐Mintzer, O., Walsh, M. D., & Ballenger, J. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199510000-00011 · Cited by 16
Combination Pharmacotherapy in Alcoholism: A Novel Treatment Approach
Farren, C. K., Rezvani, A. H., Overstreet, D. H., et al. (2000) · CNS Spectrums · doi:10.1017/s1092852900012839 · Cited by 15
Sertraline in the treatment of patients with social phobia
Martins, E. A., Pigott, T. A., BERNSTEIN, S. E., Doyle, B. B., Sunderland, B., Smolka, V. M., & Dubbert, B. K. (1994) · Anxiety · doi:10.1002/anxi.3070010609 · Cited by 14
A six month sertraline fluoxetine comparative study in depressed outpatients: Outcome and costs
Bisserbe, J. C., Boyer, P., Souêtre, E., et al. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)87960-0 · Cited by 10
Maternal self-collection of specimens for GBS culture.
Clary, C. M. (1999) · PubMed · Cited by 6
Cited by
Asymmetric Hydrogenation of Olefins Using Chiral Crabtree-type Catalysts: Scope and Limitations
Verendel, J. J., Pàmies, O., Diéguez, M., & Andersson, P. G. (2014) · Chemical Reviews · doi:10.1021/cr400037u · Cited by 505
Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity
Klaassens, B. L., van Gorsel, H. C., Khalili-Mahani, N., van der Grond, J., Wyman, B. T., Whitcher, B., Rombouts, S. A. R. B., & van Gerven, J. M. A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.08.012 · Cited by 76
Metadata
- Authors
- McRae, A. L., & Brady, K. T.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa UK Limited
- Published
- 2001-05
- Volume
- 2
- Issue
- 5
- Pages
- 883-892
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2047176101
- Cited by
- 287
- References
- 78
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.